Telo Genomics Corp V.TELO

Alternate Symbol(s): TDSGF

Telo Genomics Corp. is a Canada-based biotech company. The Company is focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions. The Company, through its wholly owned subsidiary, Telo Genomics Holdings Corp., is developing diagnostic and prognostic products for diseases that display genomic instability. Its lead product, TeloView SMM, is a high-complexity molecular assay available for clinical use to provide information to physicians treating patients with Smoldering Multiple Myeloma. Through proprietary telomere-based analysis, TeloView SMM selects high-risk SMM patients who are likely to benefit from earlier treatment intervention while identifying the larger subset of low-risk SMM patients who have a more stable form of the disease and do not require immediate treatment. The TeloView SMM assay has a potential total addressable market of over 500,000 tests per year.

TSXV:TELO - Post by User

Telo Genomics Corp

Bullboard Posts

Comment by jammingthepipelineon Nov 16, 2017 3:46pm

139 Views

Post# 26979362

RE:RE:RE:Stay Away

It looks like that this great managemnet was not able to find money at 0.40, nor did they at 0.25 cents and now it looks like it will be a PP of 0.20 cents.

Once again Jason and Hugh are absolutely inexperienced.

Bill Gates has 50 million dollars ready for Alzheimer research but DXD can't find money to close their financing.

Bullboard Posts

Quebecor achieves all Freedom Mobile acquisition commitments